WAO guideline for the management of hereditary angioedema
T Craig, EA Pürsün, K Bork, T Bowen, H Boysen… - World Allergy …, 2012 - Springer
Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and
appropriate therapy are often unknown or not available for physicians and other health care …
appropriate therapy are often unknown or not available for physicians and other health care …
Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema
C1 inhibitor deficiency (hereditary angioedema [HAE]) is a rare disorder for which there is a
lack of consensus concerning diagnosis, therapy, and management, particularly in Canada …
lack of consensus concerning diagnosis, therapy, and management, particularly in Canada …
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema
Abstract Background We published the Canadian 2003 International Consensus Algorithm
for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor …
for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor …
[HTML][HTML] The international WAO/EAACI guideline for the management of hereditary angioedema–the 2021 revision and update
Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …
[HTML][HTML] Consensus on treatment goals in hereditary angioedema: a global Delphi initiative
Background Hereditary angioedema (HAE) is a rare, life-threatening genetic disorder
characterized by recurrent episodes of subcutaneous or submucosal angioedema. The …
characterized by recurrent episodes of subcutaneous or submucosal angioedema. The …
Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and …
BACKGROUND: We published the Canadian 2003 International Consensus Algorithm for
the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1 …
the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1 …
The international WAO/EAACI guideline for the management of hereditary angioedema–the 2017 revision and update
Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and
appropriate therapy are essential. This update and revision of the global guideline for HAE …
appropriate therapy are essential. This update and revision of the global guideline for HAE …
Canadian hereditary angioedema guideline
S Betschel, J Badiou, K Binkley, J Hébert… - Allergy, Asthma & …, 2014 - Springer
Hereditary angioedema (HAE) is a disease which is associated with random and often
unpredictable attacks of painful swelling typically affecting the extremities, bowel mucosa …
unpredictable attacks of painful swelling typically affecting the extremities, bowel mucosa …
The burden of illness in patients with hereditary angioedema
A Banerji - Annals of Allergy, Asthma & Immunology, 2013 - Elsevier
Objective Hereditary angioedema (HAE) is a rare genetic disease characterized by long-
term recurrent attacks of subcutaneous or submucosal edema in different parts of the body …
term recurrent attacks of subcutaneous or submucosal edema in different parts of the body …
The International/Canadian hereditary angioedema guideline
S Betschel, J Badiou, K Binkley, R Borici-Mazi… - Allergy, Asthma & …, 2019 - Springer
This is an update to the 2014 Canadian Hereditary Angioedema Guideline with an
expanded scope to include the management of hereditary angioedema (HAE) patients …
expanded scope to include the management of hereditary angioedema (HAE) patients …